Florintree Advisors, an alternate investment firm set up by former Blackstone India co-head, Mathew Cyriac has picked up an 80% stake in Accutest Research Laboratories, one of India’s leading independent clinical...
Torrent Pharmaceuticals to acquire 100% of Curatio Healthcare for Rs 2,000 crores
Ahmedabad-based Torrent Pharmaceuticals Limited has entered into a definitive agreement to acquire 100% of skincare manufacturer Curatio Healthcare for Rs. 2,000 crores. Skincare product maker- Curatio has a strong...
Biocon sells 5.4% stake in arm Syngene International for Rs 1,220 cr
Drugmaker Biocon on Tuesday divested a 5.4 per cent stake in its research arm Syngene International for a little over Rs 1,220 crore through an open market transaction. According to bulk deal data available with the...
Fountainvest, TPG, Warburg among bidders for Carlyle’s Ambio stake – sources
Private equity firms Fountainvest Capital Partners, TPG and Warburg Pincus are among final-round bidders for Carlyle Group’s stake in AmbioPharm Inc, people with knowledge of the transaction told Reuters. Carlyle...
Piramal, Cadila among 32 companies in race to buy Sharon Bio-Medicine
Piramal Pharma, Cadila Pharmaceuticals, Shamrock Pharmachemi and ACG Associated Capsules are among the 32 entities in the fray to acquire Sharon Bio-Medicine, which is undergoing a second round of insolvency...
CCI clears deal involving Sekhmet Pharmaventures, Optimus Drugs
The Competition Commission of India approved the proposed deal involving Sekhmet Pharmaventures and Optimus Drugs Pvt Ltd. Under the transaction, Sekhmet would buy a majority shareholding in Optimus Drugs. The fair...
NCLT approves demerger of pharma business from Piramal Enterprises
The National Company Law Tribunal on Friday approved the demerger of Piramal Enterprises’ (PEL) pharma business and the simplification of the company’s corporate structure. The order paves the way towards creation of...
Advent to sell Bioduro stake, eyes valuation over $1 bln – sources
Buyout firm Advent International plans to sell a majority stake in U.S.-based Bioduro-Sundia in a deal that could value the drug development and manufacturing outsourcing provider at over $1 billion, said three people...
Intas & Dr Reddy’s in race with PEs to buy US’ Athenex
India’s Intas Pharmaceuticals and Dr Reddy’s Laboratories are in talks to acquire Athenex Inc in a $200-250 million (₹1,580-1,980 crore) deal, as the US-based biotechnology firm looks to sell a controlling...
LIC reduces stake by 2% in Sun Pharma to 5.024%
Life insurance giant, LIC on Monday announced offloading of a portion of its stake in pharma major, Sun Pharmaceuticals Industries. LIC has trimmed its stake by 2.002% in the pharma company. Both LIC and Sun Pharma...
GSK spins off $36 billion consumer-healthcare business Haleon
GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant. The new stand-alone company, called...
Piramal Enterprises gets shareholders’ nod to demerge pharma business
Ajay Piramal-owned Piramal Enterprises has received shareholders’ approval to demerge its pharmaceuticals business and simplify the corporate structure. The company received 99 per cent of the votes at the shareholders...
